1-(3-(3,5-dimethylphenyl)-5-(5-fluoro-1H-benzo[d]imidazol-2-yl)pyridin-4-yl)piperidin-4-amine

ID: ALA4866325

PubChem CID: 164624123

Max Phase: Preclinical

Molecular Formula: C25H26FN5

Molecular Weight: 415.52

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1cc(C)cc(-c2cncc(-c3nc4cc(F)ccc4[nH]3)c2N2CCC(N)CC2)c1

Standard InChI:  InChI=1S/C25H26FN5/c1-15-9-16(2)11-17(10-15)20-13-28-14-21(24(20)31-7-5-19(27)6-8-31)25-29-22-4-3-18(26)12-23(22)30-25/h3-4,9-14,19H,5-8,27H2,1-2H3,(H,29,30)

Standard InChI Key:  JJAYZXFBENXPTI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   25.8804   -5.6295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8793   -6.4532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5915   -6.8663    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3052   -6.4527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3024   -5.6259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5897   -5.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0097   -5.2159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7233   -5.6236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4290   -5.2130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4264   -4.3908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7080   -3.9809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0053   -4.3980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5857   -4.4050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2981   -3.9914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2976   -3.1736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5864   -2.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8739   -3.1728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8728   -3.9967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5870   -1.9420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.7021   -3.1596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1422   -5.6193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1685   -5.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0828   -4.4050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.4179   -5.5544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8709   -4.9473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2792   -4.2383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8730   -3.5301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0544   -3.5298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6438   -4.2436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0565   -4.9488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6406   -2.8186    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  5  7  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  6 13  1  0
 16 19  1  0
 11 20  1  0
  9 21  1  0
 22 23  2  0
 23 26  1  0
 25 24  1  0
 24 22  1  0
  1 22  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 28 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4866325

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 415.52

Molecular Weight (Monoisotopic): 415.2172

AlogP: 4.98

#Rotatable Bonds: 3

Polar Surface Area: 70.83

Molecular Species: BASE

HBA: 4

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.24

CX Basic pKa: 10.00

CX LogP: 3.98

CX LogD: 1.41

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.50

Np Likeness Score: -1.10

References

1. Ishida A, Okabe Y, Matsushita T, Sekiguchi T, Nishio T, Komagata T, Iwaki M, Miyata H, Katagi J, Naganawa A, Maruyama T, Imagawa A..  (2021)  Design, synthesis, and biological evaluation of novel somatostatin receptor subtype-2 agonists: Optimization for potency and risk mitigation of hERG and phospholipidosis.,  49  [PMID:34626901] [10.1016/j.bmc.2021.116424]

Source

Source(1):

• Scientific Literature